Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed May 17, 2023
- Accession no.
- 0001447362-23-000078
- Filed
- May 17, 2023
- Trade date
- May 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 14 non-derivative transactions. Open-market sales total $194.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2023 | Common Stock | SSaleDisposed | −1,538 | $23.45F2 | −$36,066.1 | 150,443 | Direct | |
| May 15, 2023 | Common Stock | SSaleDisposed | −769 | $23.45F2 | −$18,033.05 | 112,785 | Indirect | |
| May 15, 2023 | Common Stock | SSaleDisposed | −769 | $23.45F2 | −$18,033.05 | 101,680 | Indirect | |
| May 15, 2023 | Common Stock | SSaleDisposed | −384 | $23.45F2 | −$9,004.8 | 19,834 | Indirect | |
| May 15, 2023 | Common Stock | SSaleDisposed | −384 | $23.45F2 | −$9,004.8 | 19,834 | Indirect | |
| May 15, 2023 | Common Stock | SSaleDisposed | −384 | $23.45F2 | −$9,004.8 | 19,834 | Indirect | |
| May 15, 2023 | Common Stock | SSaleDisposed | −384 | $23.45F2 | −$9,004.8 | 19,828 | Indirect | |
| May 16, 2023 | Common Stock | SSaleDisposed | −1,254 | $22.82F9 | −$28,616.28 | 149,189 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −627 | $22.82F9 | −$14,308.14 | 112,158 | Indirect | |
| May 16, 2023 | Common Stock | SSaleDisposed | −627 | $22.82F9 | −$14,308.14 | 101,053 | Indirect | |
| May 16, 2023 | Common Stock | SSaleDisposed | −313 | $22.82F9 | −$7,142.66 | 19,521 | Indirect | |
| May 16, 2023 | Common Stock | SSaleDisposed | −313 | $22.82F9 | −$7,142.66 | 19,521 | Indirect | |
| May 16, 2023 | Common Stock | SSaleDisposed | −313 | $22.82F9 | −$7,142.66 | 19,521 | Indirect | |
| May 16, 2023 | Common Stock | SSaleDisposed | −313 | $22.82F9 | −$7,142.66 | 19,515 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $22.830 to $23.620, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $22.650 to $23.215, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.